Caelyx as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease and/or Age Over 65 Years
Clinical trial NCT00563953 · COMPLETED
Trial details
- NCT number
- NCT00563953
- Sponsor
- SOLTI Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2011-02-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.